Zannettino AC - Search Results

1

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM. Atkins GJ, et al. Among authors: zannettino ac. Bone. 2001 Apr;28(4):370-7. doi: 10.1016/s8756-3282(01)00404-5. Bone. 2001. PMID: 11336917

2

Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells.

Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ. Gronthos S, et al. Among authors: zannettino ac. J Bone Miner Res. 1999 Jan;14(1):47-56. doi: 10.1359/jbmr.1999.14.1.47. J Bone Miner Res. 1999. PMID: 9893065 Free article.

3

Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis.

Atkins GJ, Bouralexis S, Evdokiou A, Hay S, Labrinidis A, Zannettino AC, Haynes DR, Findlay DM. Atkins GJ, et al. Among authors: zannettino ac. Bone. 2002 Oct;31(4):448-56. doi: 10.1016/s8756-3282(02)00858-x. Bone. 2002. PMID: 12398939

4

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Gronthos S, et al. Among authors: zannettino ac. J Cell Sci. 2003 May 1;116(Pt 9):1827-35. doi: 10.1242/jcs.00369. J Cell Sci. 2003. PMID: 12665563

5

RANKL expression is related to the differentiation state of human osteoblasts.

Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC. Atkins GJ, et al. Among authors: zannettino ac. J Bone Miner Res. 2003 Jun;18(6):1088-98. doi: 10.1359/jbmr.2003.18.6.1088. J Bone Miner Res. 2003. PMID: 12817763 Free article.

6

Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.

Farrugia AN, Atkins GJ, To LB, Pan B, Horvath N, Kostakis P, Findlay DM, Bardy P, Zannettino AC. Farrugia AN, et al. Among authors: zannettino ac. Cancer Res. 2003 Sep 1;63(17):5438-45. Cancer Res. 2003. PMID: 14500379

7

The proliferation and phenotypic expression of human osteoblasts on tantalum metal.

Findlay DM, Welldon K, Atkins GJ, Howie DW, Zannettino AC, Bobyn D. Findlay DM, et al. Among authors: zannettino ac. Biomaterials. 2004 May;25(12):2215-27. doi: 10.1016/j.biomaterials.2003.09.005. Biomaterials. 2004. PMID: 14741587

8

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino AC. Pan B, et al. Among authors: zannettino ac. Bone. 2004 Jan;34(1):112-23. doi: 10.1016/j.bone.2003.08.013. Bone. 2004. PMID: 14751568

9

Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.

Hu YS, Zhou H, Myers D, Quinn JM, Atkins GJ, Ly C, Gange C, Kartsogiannis V, Elliott J, Kostakis P, Zannettino AC, Cromer B, McKinstry WJ, Findlay DM, Gillespie MT, Ng KW. Hu YS, et al. Among authors: zannettino ac. J Bone Miner Res. 2004 Jan;19(1):89-99. doi: 10.1359/JBMR.0301215. J Bone Miner Res. 2004. PMID: 14753741 Free article.

10

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC. Pan B, et al. Among authors: zannettino ac. J Bone Miner Res. 2004 Jan;19(1):147-54. doi: 10.1359/jbmr.2004.19.1.147. J Bone Miner Res. 2004. PMID: 14753746 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page